Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
NewLink Genetics Corporation
About LUMO
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in advancing its clinical program and focused on identifying, acquiring, developing, and commercializing products and new therapies for people with rare diseases. Its pipeline is focused on the development of an orally administered small molecule, LUM-201, which is a growth hormone (GH) secretagogue, also called ibutamoren, for rare endocrine disorders that require injectable recombinant human growth hormone (rhGH). LUM-201 is a tablet formulation that is intended to be administered once daily. LUM-201 stimulates GH via the GH secretagogue receptor (GHSR1a), also known as the ghrelin receptor, and also suppresses the release of somatostatin, thus providing a differentiated mechanism of action to treat some rare endocrine disorders (involving a deficiency of GH) by increasing the amplitude of endogenous, pulsatile GH secretion. Lumos Pharma Sub, Inc. (Private Lumos) is its subsidiary.
Find out what a historical investment in NewLink Genetics Corporation would be worth today using our LUMO stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy LUMO shares in Australia?
Buying LUMO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in NewLink Genetics Corporation in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LUMO
What is the ticker symbol of NewLink Genetics Corporation?
The ticker symbol for NewLink Genetics Corporation is LUMO.
How much is one share of LUMO?
One share of LUMO is valued at $4.34 as of 20 May 2026.
What is the market capitalisation of NewLink Genetics Corporation LUMO?
As of 20 May 2026 NewLink Genetics Corporation has a market cap of -.
What is the 52-week high for NewLink Genetics Corporation stock?
The NewLink Genetics Corporation 52-week high stock price is $NaN.
What is the 52-week low for NewLink Genetics Corporation stock?
The NewLink Genetics Corporation 52-week low stock price is $NaN.
Can I buy LUMO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy LUMO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LUMO on Stake
- Buy LUMO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of LUMO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
LUMO related stocks